Merck KGaA Rating Lowered to Sell at Societe Generale
Separately, analysts at Nomura downgraded shares of Merck KGaA from a "buy" rating to a "neutral" rating in a research note to investors on Friday, January 4th.
Join the discussion below, or Read more at AmericanBankingNews.com.
#1 Mar 31, 2013
Add your comments below
|Study: No suicide risk for anti-smoking pills||Apr 25||SUS||2|
|SocGen Picks New Favorites In Big Pharma||Apr 14||not what caused c...||1|
|Autism affects one in every 41 children in N.J.||Apr 13||Friend||1|
|Teva says it will stop making sedative linked t... (May '10)||Apr 5||Locator||13|
|Saskatchewan may have Canada's first case of Zi...||Mar 31||JUSTIN TRUDEAU ERA||1|
|Pricey prostate cancer drug's makers targeted b...||Mar 30||UTrashy||2|
|Jeremy Rifkin is Wrong on Genetically Modified ... (Jul '06)||Mar '16||john hall||2|
Find what you want!
Search Biotech Forum Now
Copyright © 2016 Topix LLC